ストックスクリーナーアプリを入手
9.06
1.68%
0.15
前日終値:
$8.91
開ける：
$8.85
24時間の取引高:
682.34K
Relative Volume:
0.61
時価総額：
$661.27M
収益：
-
当期純損益:
$-86.60M
株価収益率:
-3.1987
EPS:
-2.8324
ネットキャッシュフロー:
$-67.37M
1週間 パフォーマンス:
+0.22%
1か月 パフォーマンス:
-5.62%
6か月 パフォーマンス:
+196.08%
1年 パフォーマンス:
+46.13%
1日の値動き範囲:
$8.75
$9.23
1週間の範囲:
$8.75
$9.69
52週間の値動き範囲:
$1.45
$10.38
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
名前
Lexeo Therapeutics Inc
セクター
電話
(212) 547-9879
住所
345 PARK AVENUE SOUTH, NEW YORK
LXEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
9.06 | 650.32M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-10-15 | 開始されました | Guggenheim | Buy |
| 2025-07-31 | 開始されました | Oppenheimer | Outperform |
| 2024-06-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-06-06 | 開始されました | H.C. Wainwright | Buy |
| 2023-11-28 | 開始されました | Chardan Capital Markets | Buy |
| 2023-11-28 | 開始されました | JP Morgan | Overweight |
| 2023-11-28 | 開始されました | Leerink Partners | Outperform |
| 2023-11-28 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-11-28 | 開始されました | Stifel | Buy |
すべてを表示
Lexeo Therapeutics Inc (LXEO) 最新ニュース
Savant Capital LLC Invests $119,000 in Lexeo Therapeutics, Inc. $LXEO - MarketBeat
Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 1,127 Shares of Stock - MarketBeat
Lexeo Therapeutics (NASDAQ:LXEO) Coverage Initiated at Cantor Fitzgerald - MarketBeat
Adler, Lexeo Therapeutics CMO, sells $5.7k in LXEO stock By Investing.com - Investing.com Australia
Lexeo Therapeutics CEO Makes Significant Stock Sale! - TipRanks
Balyasny Asset Management L.P. Increases Stake in Lexeo Therapeutics Inc. - GuruFocus
Adler, Lexeo Therapeutics CMO, sells $5.7k in LXEO stock - Investing.com India
Cantor Fitzgerald Initiates Coverage on Lexeo Therapeutics With Overweight Rating, $19 Price Target - MarketScreener
Equities Analysts Set Expectations for LXEO FY2025 Earnings - MarketBeat
Real time pattern detection on Lexeo Therapeutics Inc. stockMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsWeekly Market Summary & Real-Time Volume Triggers - newser.com
Will Lexeo Therapeutics Inc. price bounce be sustainableGold Moves & Daily Entry Point Alerts - newser.com
Using data models to predict Lexeo Therapeutics Inc. stock movementQuarterly Trade Review & Reliable Entry Point Alerts - newser.com
Institutional Investors Are Lexeo Therapeutics, Inc.'s (NASDAQ:LXEO) Biggest Bettors and Were Rewarded After Last Week's US$70m Market Cap Gain - 富途牛牛
Lexeo Therapeutics Insiders Benefitted From Selling Stock At US$7.01 - simplywall.st
Optimistic Buy Rating for Lexeo Therapeutics Driven by High-Dose Potential and Superior Safety Profile - TipRanks
V2Y Corporation Ltd Expands into Renewable Energy and Commodities - The Globe and Mail
Can Lexeo Therapeutics Inc. stock withstand economic slowdownWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Using data filters to optimize entry into Lexeo Therapeutics Inc.Portfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteriaTrade Risk Assessment & Fast Moving Stock Trade Plans - newser.com
Long term hold vs stop loss in Lexeo Therapeutics Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Best data tools to analyze Lexeo Therapeutics Inc. stockQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - newser.com
Should you hold or exit Lexeo Therapeutics Inc. now2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com
How Lexeo Therapeutics Inc. stock reacts to bond yieldsJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
Using Python tools to backtest Lexeo Therapeutics Inc. strategiesMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com
What to do if you’re stuck in Lexeo Therapeutics Inc.Market Activity Report & Real-Time Stock Price Movement Reports - newser.com
Is Lexeo Therapeutics Inc a good long term investmentStop Loss Placement Tips & Subscribe for Free Weekly Winners - earlytimes.in
Why hedge funds are buying Lexeo Therapeutics Inc. stock2025 Year in Review & Momentum Based Trading Ideas - newser.com
Risk vs reward if holding onto Lexeo Therapeutics Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Wall Street Analysts Predict a 124.3% Upside in Lexeo Therapeutics, Inc. (LXEO): Here's What You Should Know - sharewise.com
Research Analysts Set Expectations for LXEO FY2025 Earnings - MarketBeat
Can Lexeo Therapeutics Inc. stock double in next 5 yearsWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
Lexeo Therapeutics (NASDAQ:LXEO) Announces Earnings Results - MarketBeat
Lexeo Therapeutics Reports Decreased Losses and Strong Cash Position - TipRanks
Lexeo Therapeutics (NASDAQ:LXEO) Earns Buy Rating from Chardan Capital - MarketBeat
Lexeo Therapeutics: Behind The Rebound (NASDAQ:LXEO) - Seeking Alpha
Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - MSN
Lexeo Therapeutics (LXEO) to Release Quarterly Earnings on Wednesday - MarketBeat
Chardan Capital Maintains Lexeo Therapeutics (LXEO) Buy Recommendation - Nasdaq
Lexeo Therapeutics Inc (LXEO) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):